FXYD5 and renal carcinoma: In addition, other E-cadherin-independent mechanisms have been proposed; in particular, an association has been found between FXYD5/Dys expression, nuclear factor (NF)-κB pathway activation, and CCL-2 (NF-κB target gene) upregulation in breast and renal cancer cell lines (17, 18).